Neuropace Inc — Quarterly Cash Flow (NASDAQ:NPCE) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Total assets 96.3 M94.65 M110.2 M106.11 M107.25 M Total liabilities 86.48 M86.63 M85.94 M86.68 M88.74 M Total equity 9.82 M8.01 M24.27 M19.44 M18.52 M Total liabilities & shareholders' equities 96.3 M94.65 M110.2 M106.11 M107.25 M Total debt ————— Net debt —————

ニュース

LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates

Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

NeuroPace, Inc. (NPCE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates

リアリンク・パートナーズ、ニューロペースの株価目標を19ドルから20ドルに引き上げ

NeuroPace stock price target raised to $20 from $19 at Leerink Partners

NeuroPace stock price target raised to $19 from $18 at H.C. Wainwright

NeuroPace, Inc. (NPCE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

ニューロペース株、UBSが好調な第4四半期収益後に買い推奨を再確認し上昇

NeuroPace stock rises as UBS reiterates Buy rating after strong Q4 revenue

ニューロペース、2025年の売上高25%増、安定成長を予測

NeuroPace reports 25% revenue growth for 2025, projects steady growth